<!DOCTYPE html>
<html lang="en"
>
<head>
    <title>Infinite regress</title>
    <!-- Using the latest rendering mode for IE -->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">



<link rel="canonical" href="http://miljko.org">
        <meta name="author" content="Miloš Miljković" />

    <!-- Enable latex plugin -->


    <!-- Open Graph tags -->
        <meta property="og:site_name" content="Infinite regress" />
        <meta property="og:type" content="website"/>
        <meta property="og:title" content="Infinite regress"/>
        <meta property="og:url" content="http://miljko.org"/>
        <meta property="og:description" content="Infinite regress"/>

    <meta name="twitter:card" content="summary">
        <meta name="twitter:site" content="@miljko">
        <meta name="twitter:creator" content="@miljko">
    <meta name="twitter:domain" content="http://miljko.org">

    <!-- Bootstrap -->
        <link rel="stylesheet" href="http://miljko.org/theme/css/bootstrap.aplan.min.css" type="text/css"/>
    <link href="http://miljko.org/theme/css/font-awesome.min.css" rel="stylesheet">

    <link href="http://miljko.org/theme/css/pygments/native.css" rel="stylesheet">
        <link href="http://miljko.org/theme/css/typogrify.css" rel="stylesheet">
    <link rel="stylesheet" href="http://miljko.org/theme/css/style.css" type="text/css"/>

        <link href="http://miljko.org/rss/index.xml" type="application/rss+xml" rel="alternate"
              title="Infinite regress RSS Feed"/>


    <style type="text/css">
    p {
        margin-top: 18px;
        margin-bottom: 18px;
    }
    </style>

</head>
<body>

<div class="navbar navbar-default navbar-fixed-top" role="navigation">
    <div class="container">
        <div class="navbar-header">
            <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-ex1-collapse">
                <span class="sr-only">Toggle navigation</span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
            </button>
            <a href="http://miljko.org/" class="navbar-brand">
Infinite regress            </a>
        </div>
        <div class="collapse navbar-collapse navbar-ex1-collapse">
            <ul class="nav navbar-nav">
                        <li >
                            <a href="http://miljko.org/category/blog.html">Blog</a>
                        </li>
                        <li >
                            <a href="http://miljko.org/category/pisanije.html">Pisanije</a>
                        </li>
                        <li >
                            <a href="http://miljko.org/category/reviews.html">Reviews</a>
                        </li>
            </ul>
            <ul class="nav navbar-nav navbar-right">
                <li><a href="http://miljko.org/archives.html"><i class="fa fa-th-list"></i><span class="icon-label">Archives</span></a></li>
            </ul>
        </div>
        <!-- /.navbar-collapse -->
    </div>
</div> <!-- /.navbar -->

<div class="container">
    <div class="row">
        <div class="col-lg-12">

            <article>
                <h2><a href="http://miljko.org/eng/2016/01/02/locked-in/">Locked&nbsp;in</a></h2>
                <div class="summary"><p>Two years ago, I haplessly expressed excitement about my task list manager of choice being updated&nbsp;soon.</p>
<blockquote class="twitter-tweet" lang="en"><p lang="en" dir="ltr">Speaking of <a href="https://twitter.com/culturedcode">@culturedcode</a>, looks like Things 3 is progressing nicely. Hope “more structure” is code for dependencies. <a href="http://t.co/ctwycDyL1e">pic.twitter.com/ctwycDyL1e</a></p>&mdash; Miloš Miljković (@Miljko) <a href="https://twitter.com/Miljko/status/429958780886196224">February 2, 2014</a></blockquote>

<p><script async src="//platform.twitter.com/widgets.js" charset="utf-8"></script></p>
<p>It hasn&#8217;t yet. Two iterations of iOS and an Apple Watch later, Things 3 is still
not available, and I am becoming increasingly annoyed. Inside my mind, two kinds
of costs—Ms. Sunken and Mr. Opportunity—are battling it&nbsp;out.</p>
<p>Mr. O has me thinking about time wasted on not being able to turn a next action
into a project; or having to make too many taps to edit anything in the iOS app.
And then I stress out even more contemplating all the features I don&#8217;t even know
I&#8217;m missing out on—not wanting to find out about those is why I not dare read
reviews of the&nbsp;competition.</p>
<p>Ms. S, meanwhile, is raising dread whenever I thinking about moving to Omnifocus, Taskpaper, or whatever the <span class="caps">GTD</span> app du jour is—knowing that I would be trading a set of known deficiencies for a potentially grater set of unfamiliar&nbsp;ones.</p>
<p>The mister and missus are irrational beings—even though Things 3 remains
vaporware, there have been a few 2.x updates that iOS7-fied the experience—from
going flat to adding extensions and notification center widgets. All that
considered, I should not
spend so much time thinking about an&nbsp;app.</p>
<p>And yet, it is 6pm on January 2, 2016, and instead of writing about getting back to the lab, <em>finally</em> finishing the PhD thesis, or being a haughty gastro-tourist in unseasonably warm New Orleans, I am being much too first-worldly for my Balkano-Serbian&nbsp;comfort.</p>
<p>Which I will add to the pile of absurd reasons for why I dislike Cultured&nbsp;Code.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2016/01/02/locked-in/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/srb/2015/11/24/sve-se-vraca/">Sve se&nbsp;vraća</a></h2>
                <div class="summary"><p>Brzo: koje su još uvek profitabilne izvozne industrije u&nbsp;Srbiji?</p>
<p>Poljoprivreda, <span class="caps">OK</span>.</p>
<p>Ljudi,&nbsp;naravno.</p>
<p><a href="http://www.kurir.rs/srpske-fabrike-izvoz-oruzja-vredan-300-miliona-dolara-clanak-1235305">Još&nbsp;nešto?</a></p>
<p><a href="http://www.novosti.rs/vesti/naslovna/drustvo/aktuelno.290.html:517588-Od-izvoza-oruzja-milijarda-dolara">Uopšte nije&nbsp;teško.</a></p>
<p>Ovakvi&nbsp;naslovi:</p>
<blockquote>
<p><a href="http://arhiva.alo.rs/aktuelno/vesti/vucic-i-dinkic-spremaju-izvoz-oruzja-arapima/2049">Vučić i Dinkić spremaju izvoz oružja&nbsp;Arapima!</a></p>
</blockquote>
<p>se brzo zaborave. A onda vam ljudi sa progrešnog kraja nišana koji ste prodali
u trideset i petom poslovnom poduhvatu stoleća zakucaju na&nbsp;vrata.</p>
<p>Zatim pročitate <a href="http://www.newyorker.com/news/news-desk/belgian-terror-brussels-on-lockdown">gde evropski teroristi nabavljaju oružje</a>
(za nestrpljive: u Briselu), i <a href="http://www.blic.rs/Vesti/Ekonomija/288716/Srbija-najvise-oruzja-izvozi-u-SAD-Irak-Italiju-i-Belgiju">spisak najvećih uvoznika srpskih
rukotvorina</a> vam postane jasniji (Belgija je bila na četvrtom&nbsp;mestu).</p>
<p>Ovo nije problem samo sadašnje vlasti—i prethodnici su se <a href="http://www.rts.rs/page/stories/sr/story/13/Ekonomija/659351/Izvoz+oružja%2C+ali+i+pameti.html">ponosili
dostignućima srpske metalurgije</a>.</p>
<p>Zato mi je drago što se Srbija—i ljudi i državne strukture—prema
izbeglicama ophodi bolje nego komšije. Ali, nemojmo se pretvarati da je
država samo nedužni posmatrač onoga što se dešava na Bliskom&nbsp;Istoku.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/srb/2015/11/24/sve-se-vraca/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2015/11/17/rhimes-on-work/">Shonda Rhimes on&nbsp;work</a></h2>
                <div class="summary"><blockquote>
<p>Work will happen 24 hours a day, 365 days of the year, if you let it. We are all in that place where we are all letting it for some reason, and I don’t know&nbsp;why.</p>
</blockquote>
<p>Via <a href="http://calnewport.com/blog/2015/11/17/shonda-rhimes-doesnt-check-e-mail-after-7-pm/">Cal Newport&#8217;s&nbsp;blog</a></p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2015/11/17/rhimes-on-work/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2015/11/12/ios-posting-test/">Can you post to a Pelican blog from&nbsp;iOS?</a></h2>
                <div class="summary"><p>It looks like you can, provided you have a server running somewhere. Mine is a 2013 MacBook Pro with a dying&nbsp;battery.</p>
<p>This one I&#8217;m writing in Drafts, which will then copy the post to a Dropbox folder monitored by Hazel. This should trigger a simple bash script that processes the markdown file and pushes the newly created html files to&nbsp;github.</p>
<p>Very Rube Goldberg-y, I know. I&#8217;ll try doing it from Editorial&nbsp;next.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2015/11/12/ios-posting-test/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2015/11/12/hd-cy-for-gvhd/">High-dose cyclophosphamide for <span class="caps">GVHD</span>&nbsp;prophylaxis</a></h2>
                <div class="summary"><p>That high-dose cyclophosphamide is being used for haploidentical donor
transplants is well-known in circles that know what haploidentical
transplants are. When I saw that Hopkins transplanters used it as
single-agent prophylaxis in <span class="caps">HLA</span>-matched related donor transplants, I was intrigued
enough to do a full literature review. This is the result, presented as
a slightly-too-long fellow lecture, all 100+ slides of&nbsp;it.</p>
<p>Since I have a hard time remembering facts unless I know the history
behind them, the section about the works of Dr. George Santos is rather
long. It was also important to show that crude animal models can be
both helpful (in telling you that higher doses of cyclophosphamide work
better for <span class="caps">GVHD</span> prophylaxis that lower) and misleading (in making you
think high-dose Cy is toxic to hematopoietic stem cells, thus changing your
clinical trial&nbsp;design).</p>
<p><object data=http://miljko.org/slides/cy width="600" height="400"> <embed src=http://miljko.org/slides/cy width="600" height="400"> </embed> Error: Embedded data could not be displayed. </object></p>
<p><a href="http://miljko.org/slides/cy/index.html">You can view a full-screen version of the slideshow here</a>.</p>
<p>As this may be incomprehensible without someone explaining
the slides, I may one day upload a version with a&nbsp;voice-over.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2015/11/12/hd-cy-for-gvhd/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2015/08/14/programming-medicine/">Programming, meet&nbsp;medicine</a></h2>
                <div class="summary"><p><a href="https://twitter.com/siracusa">John Siracusa</a> is a programmer. <a href="https://en.wikipedia.org/wiki/Merlin_Mann">Merlin Man</a> is
a <a href="http://43folders.com">lifehack guru</a>-cum-<a href="https://twitter.com/hotdogsladies">internet personality</a>. If you
are in a medical field, there is no particular reason you would know&nbsp;them.</p>
<p>They co-host <a href="http://relay.fm/rd">a podcast</a> that modestly has themselves as the
subject matter. It is one of the best new podcasts this year, second only to
<a href="http://relay.fm/cortex"><span class="caps">CGP</span> Grey&#8217;s</a> (though with <a href="http://5by5.tv/roadwork">Road Work</a> coming out this week,
it may be a three-way tie). In this week&#8217;s episode, Siracusa had this to
say about programmers (<a href="https://overcast.fm/+EtBou_7cc/39:00">link to the audio here</a>—it sounds better than it&nbsp;reads):</p>
<blockquote>
<p>Plenty of people can espouse information telling some younger programmer
&#8220;make sure you always call &#8216;srand&#8217; before you call &#8216;rand&#8217;&#8221;, and they can
easily tell you &#8220;don&#8217;t listen to that guy, you should not call &#8216;srand&#8217; before you
call&nbsp;&#8216;rand&#8217;&#8221;.</p>
<p>Neither one of them really understands it, because they can&#8217;t
explain it. If that young programmer is saying &#8220;But why? But why? Why? How do these
things work together? Explain it to me.&#8221; and they realize &#8220;Oh, I can&#8217;t explain
it. All I have is this…&#8221;—it&#8217;s not a cargo cult, but it&#8217;s more like—&#8221;I have this
practice that I&#8217;ve learned through supposed bitter experience that if I didn&#8217;t
do this one time and something didn&#8217;t work, then I did do it, then it did work.&#8221;
Very often in programming you can sort of learn that way where basically &#8220;I
tried this one thing and it didn&#8217;t work, or this bug happened, then (I did) this other
thing, and the bug was fixed&#8221;, and come away from that with a rule, or
a heuristic, or something you think is an unwritten law without actually
understanding the&nbsp;underlying…</p>
</blockquote>
<p>Remind you of anything? In medicine, <a href="https://en.wikipedia.org/wiki/Cargo_cult">&#8220;cargo cult&#8221;</a> is exactly<br>
the term I would use. Programming&#8217;s saving grace is that it is a finite
system created by humans, and—at least in theory—knowable. The human
body is as black a box as it ever was—the only difference between now
and the 1800s being a stronger&nbsp;flashlight.</p>
<p>So, programming clearly shares this with medicine: most of its practitioners
don&#8217;t have a firm grasp of what they are doing, and don&#8217;t understand the
underlying principles of their craft. Why, then, do we fool ourselves that <em>adding</em>
programmers&#8217; idiosyncracies to physicians&#8217; by the way of electronic medical
records, clinical decision support systems, and ultimately <span class="caps">AI</span>-run <em>e-doctors</em>, will
somehow &#8220;fix&#8221; medicine instead of making it bad in a different&nbsp;way?</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2015/08/14/programming-medicine/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/srb/2015/07/22/nih-lecenje/">Lečenje u <span class="caps">NIH</span>-u</a></h2>
                <div class="summary"><p>Jedna od mnogih stvari po kojima se <span class="caps">NIH</span> razlikuje od ostalih
zdravstvenih ustanova je da pacijenti ne plaćaju ništa. Zdravstveno
osiguranje nije potrebno, lekovi—od kojih mnogi koštaju $1.000 po
dozi—se samo pokupe u apoteci, a ako živite daleko od Betezde <em>platiće
vam</em> (domaći) let, voz, gorivo. Do pre 10-15 godina plaćali su i hotele,
sada je tu samo dnevnica od&nbsp;$50.</p>
<p>I meni najzanimljivije—ne leče samo državljane. Štaviše, na nekim
protokolima ima više legalnih i ilegalnih imigranata iz Centralne i
Južne Amerike nego Amerikanaca. Ko god se pojavi na pragu instituta i
ispunjava uslove za upis na studiju može da računa na američke poreske
obveznike. A niko neće oterati nekoga ko je veoma bolestan ali ne
ispunjava uslove, naročito ako standardnu terapiju ne može primiti kod&nbsp;kuće.</p>
<p>Zato svaki put kada čujem da se u Srbiji skuplja desetine i stotine
hiljada evra da bi se neko poslao na lečenje u Italiju, Rusiju,
ili Nemačku, pomislim na stvari koje se rade ovde i da li bi one
pomogle. Ima ih previše za nabrajanje, tako da je najbolje otići na
<a href="http://clinicaltrials.gov/">clinicaltrials.gov</a>—sajt koji ima podatke
o svim aktivnim studijama koje finansira <span class="caps">NIH</span>—i pogledati da li postoji
nešto što se <em>izvodi</em> (ne samo finansira) ovde. Ono što sam video u
poslednjih godinu dana, bez nekog&nbsp;reda:</p>
<ul>
<li>aplastična&nbsp;anemija</li>
<li>srpasta&nbsp;anemija</li>
<li>B-ćelijski&nbsp;limfom</li>
<li>primarni <span class="caps">CNS</span>&nbsp;limfom</li>
<li>transplantacija koštane srži/stem ćelija za mijelodisplastični sindrom, akutne
  leukemije,&nbsp;limfome</li>
<li>Kapoši&nbsp;sarkom</li>
<li>hairy cell&nbsp;leukemija</li>
<li>hronična limfocitna&nbsp;leukemija</li>
<li>primarni efuzioni&nbsp;limfom</li>
<li>limfogranulocitoza</li>
<li><span class="caps">LGL</span>&nbsp;leukemija</li>
<li>metastatski ili neresektabilni rak&nbsp;pankreasa</li>
<li>hepatocelularni&nbsp;karcinom</li>
<li>holangiokarcinom</li>
<li>metastatski rak debelog&nbsp;creva</li>
<li>metastatski rak&nbsp;jajnika</li>
<li>trostruko-negativni metastatski rak&nbsp;dojke</li>
<li>metastatski rak grlića&nbsp;materice</li>
<li>rak&nbsp;bešike</li>
<li>rak prostate rezistentan na hormonsku&nbsp;terapiju</li>
<li>metastatski rak&nbsp;pluća</li>
<li>mezoteliom pleure i/ili&nbsp;peritoneuma</li>
<li>timom</li>
<li>adrenokortikalni&nbsp;karcinom</li>
<li>metastatski&nbsp;melanom</li>
</ul>
<p>Ovo ne uključuje pedijatrijska oboljenja, kojih ima još toliko. I ne uključuje
bolesti koje sam video van Instituta, pošto vam u drugim akademskim centrima
u Americi računi stižu iako ste na&nbsp;studiji.</p>
<p>U većini slučajeva se nekome iz Srbije sa metastatskim rakom ne bi
isplatilo da prelazi okean kako bi primio eksperimentalnu terapiju čija se
efikasnost još istražuje. Ali, treba se raspitati—mogu da zamislim situaciju
u kojoj bi itekako&nbsp;vredelo.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/srb/2015/07/22/nih-lecenje/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2015/07/01/a-yearly-welcome/">A yearly&nbsp;welcome</a></h2>
                <div class="summary"><p>July 1st is when most <span class="caps">US</span> residency programs let their new interns loose
after a week of corporate compliance training and <span class="caps">ACGME</span>-mandated talks
about&nbsp;burnout.</p>
<p><a href="https://thewinnower.com/papers/advice-for-physicians-in-training-40-tips-from-40-docs">If you are a medical student or a new intern, read&nbsp;this.</a></p>
<p><a href="http://miljko.org/eng/2014/06/03/three-tech-tips-for-new-interns/">And this short post of mine still&nbsp;applies.</a></p>
<p>In addition, remember that it is easy to become very cynical very quickly.
That is not the best of defense mechanisms, but it is better than substance
abuse, domestic violence, or suicidal ideation. So, if you <em>have to</em> be
cynical, do it <em>up</em> the chain of command, not down or laterally. That
way you will avoid preconditioning medical students, observers, and your
fellow interns. The senior residents will either support you in your
jadedness, or will get to feel smug when they tell you that you are too
young for that much cynicism. Your attendings should, ideally, teach you
why you are wrong—though the younger they are the more likely it is they
will behave like senior residents. So it&#8217;s a win for everyone, really, unless
someone dings you for lack of&nbsp;professionalism.</p>
<p>Also, please remember to&nbsp;eat.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2015/07/01/a-yearly-welcome/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/eng/2015/05/29/the-overhead/">The&nbsp;overhead</a></h2>
                <div class="summary"><p>There are many misnomers in American medical English. Patients walk into
your <em>clinic</em> (from Greek <em>kline</em>, bed) to learn whether their scan was
<em>negative</em> (good) or <em>positive</em> (bad). Those who have severe chronic
pain may ask for their <em>pain medicine</em> (that relieve pain, not cause
it), usually opioids. Some physicians would call them <em>pain-seeking</em>
(though what they are seeking is relief). If they don&#8217;t get a prescription,
they may rate their doctor poorly on a patient satisfaction survey,
which is a big thing if you are into <em>quality improvement</em>. <em>Quality</em>
improvement. There&#8217;s a&nbsp;misnomer.</p>
<p><em>Quality improvement</em> in medicine is <a href="http://www.hrsa.gov/quality/toolbox/methodology/qualityimprovement/index.html">by definition</a>
limited to improving things you can measure, i.e. quantify, i.e. judge
by criteria that are the <em>ying</em> to quality&#8217;s <em>yang</em>. Those measures may
be valid or not, and may improve patients&#8217; lives, longevity, etc. (or
not) but they are not quality. Because they are measures. Numbers. You
know,&nbsp;quantities.</p>
<p>The movement is dangerous in at least three ways. Firstly and most
obviously, many of the things being measured haven&#8217;t been validated
in prospective trials. They are either (poor) conjecture—like tight
glycemic control for type <span class="caps">II</span> diabetics assumed to help because of good
outcomes in type ones (since, you know, a skinny teenager and a morbidly
obese 60-year-old are similar that way.) Or they came out of a corporate
think-tank cocaine-fueled outside-the-box brainstorming session, like
patient satisfaction scores<sup id="fnref:pg"><a class="footnote-ref" href="#fn:pg" rel="footnote">1</a></sup>.</p>
<p>Secondly, even if they were the best measures in the world, tying them
to promotion and compensation would have the unintended consequence
of having practitioners loose sight of all other aspects of medicine,
including the patient. There are many accounts of how it can
happen—<a href="http://www.medrants.com/archives/8134">this one from Dr. Centor comes readily to mind</a>—but
since (1) identifying and (2) addressing the patient&#8217;s actual problem is
difficult to measure objectively, it is not one of the&nbsp;benchmarks.</p>
<p>And finally, wherever there are numbers and money, techniques will
evolve to game the system. <a href="http://davidsimon.com/the-bad-math/">David Simon&#8217;s account of how this happens
in law enforcement</a> is applicable. Want fewer central line
infections? Enact a policy not to draw blood cultures from central
lines! Too many nosocomial urinary tract infections? Urinalyses on
admission for everyone! Hospitals create teams with dozens of people
whose only job is to find new and better ways to do this. And they have
to—because everyone else is doing it. A depressing amount of time,
money, and effort wasted because of pointless exercises of anonymous&nbsp;pencil-pushers.</p>
<p>This is how you get to <a href="http://thedoctorweighsin.com/the-rise-of-the-machine-how-hospitalpractice-admins-have-assumed-control/">a near 3000% increase in the number of hospital
administrators over 30 years</a>. I am sure they are all good
people, <a href="http://www.nytimes.com/2014/05/18/sunday-review/doctors-salaries-are-not-the-big-cost.html">with good salaries</a>, but they are, for the most part,
insignificant. An epiphenomenon induced by someone&#8217;s desire to turn
healthcare into an industry, forgetting that the six sigma ideology that
works so well for toaster ovens can&#8217;t be forced onto moist, squishy, and
fragile&nbsp;humans.</p>
<p>Which is also a good working definition of quality&nbsp;improvement.</p>
<div class="footnote">
<hr>
<ol>
<li id="fn:pg">
<p>Some speculation on my end there. They might have been on <span class="caps">LSD</span>.&#160;<a class="footnote-backref" href="#fnref:pg" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
</ol>
</div>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/eng/2015/05/29/the-overhead/">more ...</a>
                </div>
            </article>
            <hr/>
            <article>
                <h2><a href="http://miljko.org/srb/2015/05/19/zbogom-nemanjino/">Zbogom,&nbsp;Nemanjino</a></h2>
                <div class="summary"><p>Prošle godine u ovo vreme sam, i ne primetivši, prešao značajan životni
<em>miljokaz</em>—moje dalje usavršavanje neće zavisiti od dobre volje srpske&nbsp;birokratije.</p>
<p>Stranci koji žele specijalizaciju u Americi a nemaju zelenu kartu mogu
birati između dve vrste lanaca—<span class="caps">H1B</span> i J1 vize. Ova prva je radna viza,
skuplja, i većina akademskih programa je ne sponzoriše. J1 je poznata
studentima iz Srbije koji dolaze u <span class="caps">SAD</span> preko <em>work and travel</em> programa.
Postoji posebna verzija J1 vize za lekare, koja je zasnovana na sledećim&nbsp;pretpostavkama:</p>
<ul>
<li>u zemlji iz koje dolazite postoji potreba za lekarima određene specijalizacije,&nbsp;ali</li>
<li>ne postoje kapaciteti za školovanje tih specijalista, tako&nbsp;da</li>
<li>strana zemlja šalje lekara u Ameriku,&nbsp;ali</li>
<li>pod uslovom da se nakon završetka specijalizacije vrati u svoju zemlju na bar dve&nbsp;godine.</li>
</ul>
<p>Ako neko želi da ostane u Americi nakon završetka specijalizacije, to
može&nbsp;uraditi:</p>
<ul>
<li>nakon što provede bar dve godine u matičnoj zemlji,&nbsp;ili</li>
<li>tako što radi dve do pet godina u delu <span class="caps">SAD</span> sa manjkom lekara te&nbsp;specijalnosti.</li>
</ul>
<p>Prve četiri stavke su vrhunsko licimerje sa američke strane, jer su
baš njima potrebni lekari generalno, a naročito specijalizanti. Broj
medicinskih fakulteta je decenijama bio ograničem zbog straha lekarskog
lobija da će hiperprodukcijom doći do pojeftinjenja radne snage
(khm<em>Srbija</em>khm). Iz moje perspektive—hvala&nbsp;im.</p>
<p>Na žalost, to znači da od države morate dobiti potvrdu da je sve
gore navedeno tačno. Za Srbiju, ovo je čist kabuki. Ako i postoji
potreba za nekom specijalnošću, nema se para za plaćanje svršenog
specijaliste—naročito ako vam veći deo posla obavljaju volonteri. A
svakako vam niko ne može reći kakva će biti situacija nakon četiri-pet
godina (da li se u Srbiji bilo šta može planirati na tako dugi&nbsp;rok?)</p>
<p>Procedura je haotična. Najbolje se može uporediti sa umrtvljivanjem
zubnog živca pri kojem vam zubar ne kaže koliko će zuba stradati. I ne
koristi anesteziju. A zubarska stolica je istovremeno i električna, sa
satom koji&nbsp;otkucava.</p>
<p>Karakterišu je četiri&nbsp;momenta:</p>
<ul>
<li>službenici i službenice koji ne znaju o čemu se&nbsp;radi;</li>
<li>osoba do koje dođete nakon tridesetog telefonskog poziva zna šta vam treba, ali ne sme
  to da napiše jer ne može da vam garantuje posao (iako nigde u potvrdi ne treba da
  stoji bilo šta o garantovanom zaposlenju); kada božanskom intervencijom ipak
  sastavi&nbsp;potvrdu,</li>
<li>osoba koja treba da je <em>potpiše</em> ne može to da uradi jer je na odmoru,
  službenom putu, operacionoj sali, ili lebdi iznad Sahare u balonu, izgubljena i
  bez&nbsp;kompasa;</li>
<li>vaš budući poslodavac, koji vam svake nedelje šalje podsetnik da ističe vreme
  za dobijanje&nbsp;vize.</li>
</ul>
<p>Nakon uljudnih molbi, svakodnevnih telefonskih poziva, preklinjanja na kolenima,
i pretnjama zaštitnikom za ljudska prava i—ključni momenat—medijima, izaćićete
iz zgrade u Nemanjinoj isceđeni kao krpa, ali sa dovoljno snage da otrčitite do
Fedeksa kako biste to parče papira poslali kome treba u 26 milisekunde do&nbsp;dvanaest.</p>
<p>Nije tako svakome i svaki put, ali se desilo dovoljno puta meni i ljudima koje
znam da je malo verovatno da je u pitanju nečija loša&nbsp;sreća.</p>
<p>Tema za razmišljanje: zašto Ministarstvo zdravlja ne bi pojednostavilo
i ubrzalo proceduru, ali i počelo da naplaćuje taksu od ljudi koji su
se (uglavnom) besplatno školovali, a sada idu negde gde će u bliskoj
budućnosti imati za srpske uslove više nego pristojna primanja? Indija,
najveći svetski izvoznik lekara, pre izdavanje potvrde traži od budućih
specijalizanata koji su završili državnu školu da potpišu obavezu da će,
ukoliko se ne vrate kući nakon specijalizacije, platiti oko $5.000 u&nbsp;rupijima.</p>
<p>Naravno, lako mi je to da predložim kada mi potvrda više ne treba. Ali mi
je neverovatno da je srpskoj birokratiji lakše da izvodi gore opisane
burleske nego da radi svoj posao i pošteno zaradi pare; i da se država
Srbija bez ikakve nadoknade odriče intelektualnog kapitala u koji je
prethodno uložila&nbsp;finansijski.</p>
                    <a class="btn btn-default btn-xs" href="http://miljko.org/srb/2015/05/19/zbogom-nemanjino/">more ...</a>
                </div>
            </article>
            <hr/>

        <ul class="pagination">
                <li class="prev"><a href="http://miljko.org/index6.html">&laquo;</a>
                </li>
                    <li class=""><a
                            href="http://miljko.org/index.html">1</a></li>
                    <li class=""><a
                            href="http://miljko.org/index2.html">2</a></li>
                    <li class=""><a
                            href="http://miljko.org/index3.html">3</a></li>
                    <li class=""><a
                            href="http://miljko.org/index4.html">4</a></li>
                    <li class=""><a
                            href="http://miljko.org/index5.html">5</a></li>
                    <li class=""><a
                            href="http://miljko.org/index6.html">6</a></li>
                    <li class="active"><a
                            href="http://miljko.org/index7.html">7</a></li>
                    <li class=""><a
                            href="http://miljko.org/index8.html">8</a></li>
                    <li class=""><a
                            href="http://miljko.org/index9.html">9</a></li>
                    <li class=""><a
                            href="http://miljko.org/index10.html">10</a></li>
                    <li class=""><a
                            href="http://miljko.org/index11.html">11</a></li>
                    <li class=""><a
                            href="http://miljko.org/index12.html">12</a></li>
                    <li class=""><a
                            href="http://miljko.org/index13.html">13</a></li>
                    <li class=""><a
                            href="http://miljko.org/index14.html">14</a></li>
                    <li class=""><a
                            href="http://miljko.org/index15.html">15</a></li>
                    <li class=""><a
                            href="http://miljko.org/index16.html">16</a></li>
                <li class="next"><a
                        href="http://miljko.org/index8.html">&raquo;</a></li>
        </ul>
        </div>
    </div>
</div>
<footer>
   <div class="container">
      <hr>
       <div class="row">
        <div class="col-xs-12" id="aboutme">
<p>
    <strong>About Miloš Miljković</strong><br/>
    <p>Hematologist/medical oncologist caring for patients with T-cell malignancies and relapsed solid tumors at the <a href="http://cancer.gov">National Cancer Institute</a> in Bethesda, Maryland.<p><a href="https://twitter.com/miljko">@miljko</a> on Twitter.
</p>        </div>
       </div>
      <hr>
      <div class="row">
         <div class="col-xs-10">&copy; 2018 Miloš Miljković
            &middot; Powered by <a href="http://docs.getpelican.com/" target="_blank">Pelican</a>,
            <a href="http://getbootstrap.com" target="_blank">Bootstrap</a>         </div>
         <div class="col-xs-2"><p class="pull-right"><i class="fa fa-arrow-up"></i> <a href="#">Top</a></p></div>
      </div>
   </div>
</footer>
<script src="http://miljko.org/theme/js/jquery.min.js"></script>

<!-- Include all compiled plugins (below), or include individual files as needed -->
<script src="http://miljko.org/theme/js/bootstrap.min.js"></script>

<!-- Enable responsive features in IE8 with Respond.js (https://github.com/scottjehl/Respond) -->
<script src="http://miljko.org/theme/js/respond.min.js"></script>

</body>
</html>